CHF Solutions Announces Data Demonstrating Benefit of Aquadex Therapy for Treatment of Heart Failure and COVID-19
NASDAQ,
EDEN PRAIRIE, Minn., Oct. 07, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to…
EDEN PRAIRIE, Minn., Oct. 07, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to…
These data were presented at the 24th Annual Scientific Meeting of Heart Failure Society of America.
EDEN PRAIRIE, Minn., Oct. 07, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to…
EDEN PRAIRIE, Minn., Oct. 07, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: CHFS), a medical device company dedicated to changing the lives…
EDEN PRAIRIE, Minn., Oct. 07, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to…
NAPERVILLE, IL and STANFORD, CA — A new analysis of therapy changes in the CardioMEMS Heart Sensor Allows Monitoring of…
NATIONAL HARBOR, Md. — Patients hospitalized for acute decompensated HF who were treated with adjustable ultrafiltration had a…